169 related articles for article (PubMed ID: 30037816)
21. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
22. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
23. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
24. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
[TBL] [Abstract][Full Text] [Related]
25. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
26. Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.
Antoine DJ; Sabbisetti VS; Francis B; Jorgensen AL; Craig DG; Simpson KJ; Bonventre JV; Park BK; Dear JW
Hepatology; 2015 Aug; 62(2):591-9. PubMed ID: 25891479
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinoma.
Hegele A; Heidenreich A; Kropf J; von Knobloch R; Varga Z; Hofmann R; Olbert P
Tumour Biol; 2004; 25(3):111-6. PubMed ID: 15361707
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
30. Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years.
Schulz CA; Engström G; Nilsson J; Almgren P; Petkovic M; Christensson A; Nilsson PM; Melander O; Orho-Melander M
Nephrol Dial Transplant; 2020 Feb; 35(2):265-273. PubMed ID: 30629206
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
[TBL] [Abstract][Full Text] [Related]
32. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.
Zhang PL; Mashni JW; Sabbisetti VS; Schworer CM; Wilson GD; Wolforth SC; Kernen KM; Seifman BD; Amin MB; Geddes TJ; Lin F; Bonventre JV; Hafron JM
Int Urol Nephrol; 2014 Feb; 46(2):379-88. PubMed ID: 23979814
[TBL] [Abstract][Full Text] [Related]
33. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma.
He ZH; Qin XH; Zhang XL; Yi JW; Han JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):46-54. PubMed ID: 29364470
[TBL] [Abstract][Full Text] [Related]
36. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
[TBL] [Abstract][Full Text] [Related]
37. Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma.
Mijuskovic M; Stanojevic I; Milovic N; Cerovic S; Petrovic D; Maksic D; Kovacevic B; Andjelic T; Aleksic P; Terzic B; Djukic M; Vojvodic D
Int Urol Nephrol; 2018 Jan; 50(1):63-70. PubMed ID: 29052086
[TBL] [Abstract][Full Text] [Related]
38. Composite three-marker assay for early detection of kidney cancer.
Su Kim D; Choi YD; Moon M; Kang S; Lim JB; Kim KM; Park KM; Cho NH
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):390-8. PubMed ID: 23479363
[TBL] [Abstract][Full Text] [Related]
39. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.
Southard EB; Roff A; Fortugno T; Richie JP; Kaag M; Chinchilli VM; Virtamo J; Albanes D; Weinstein S; Wilson RT
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):191-201. PubMed ID: 22086884
[TBL] [Abstract][Full Text] [Related]
40. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
